The epigenetic memory of monocytes and macrophages as a novel drug target in atherosclerosis

Clinical Therapeutics

Volumn 37, Issue 4, 2015, Pages 914-923

  Bekkering, Siroon ^a   Joosten, Leo A B ^a   Van Der Meer, Jos W M ^a   Netea, Mihai G ^b   Riksen, Niels P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

atherosclerosis; epigenetic modifications; inflammation; monocytes

Indexed keywords

CYTOKINE;

ATHEROSCLEROSIS; HUMAN; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; METABOLISM; MONOCYTE; PLAQUE, ATHEROSCLEROTIC;

ATHEROSCLEROSIS; CYTOKINES; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MACROPHAGES; MONOCYTES; PLAQUE, ATHEROSCLEROTIC;

EID: 84939938448     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2015.01.008     Document Type: Review

References (70)

1. A. Alwan, T. Armstrong, and D. Bettcher Global status report on noncommunicable diseases 2011 World Health Organization Geneva, Switzerland
2. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
3. J.M. Tarkin, F.R. Joshi, and J.H. Rudd PET imaging of inflammation in atherosclerosis Nat Rev Cardiol 11 2014 443 457
4. V.A. Triant, H. Lee, C. Hadigan, and S.K. Grinspoon Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease J Clin Endocrinol Metab 92 2007 2506 2512
5. E. Choy, K. Ganeshalingam, and A.G. Semb Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment Rheumatology (Oxford) 53 2014 2143 2154
6. P.M. Ridker, and T.F. Luscher Anti-inflammatory therapies for cardiovascular disease Eur Heart J 35 2014 1782 1791
7. I. Tabas, K.J. Williams, and J. Boren Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications Circulation 116 2007 1832 1844
8. C.K. Glass, and J.L. Witztum Atherosclerosis. the road ahead Cell 104 2001 503 516
9. L. Boring, J. Gosling, M. Cleary, and I.F. Charo Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis Nature 394 1998 894 897
10. J.M. van Gils, M.C. Derby, and L.R. Fernandes The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques Nat Immunol 13 2012 136 143
11. I. Tabas Macrophage death and defective inflammation resolution in atherosclerosis Nat Rev Immunol 10 2010 36 46
12. K.J. Moore, and I. Tabas Macrophages in the pathogenesis of atherosclerosis Cell 145 2011 341 355
13. L. Chavez-Sanchez, K. Chavez-Rueda, and M.V. Legorreta-Haquet The activation of CD14, TLR4, and TLR2 by mmLDL induces IL-1beta, IL-6, and IL-10 secretion in human monocytes and macrophages Lipids Health Dis 9 2010 117
14. C.R. Stewart, L.M. Stuart, and K. Wilkinson CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer Nat Immunol 11 2010 155 161
15. L. Chavez-Sanchez, A. Madrid-Miller, and K. Chavez-Rueda Activation of TLR2 and TLR4 by minimally modified low-density lipoprotein in human macrophages and monocytes triggers the inflammatory response Hum Immunol 71 2010 737 744
16. A.C. Newby Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability Arterioscler Thromb Vasc Biol 28 2008 2108 2114
17. K.S. Rogacev, B. Cremers, and A.M. Zawada CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography J Am Coll Cardiol 60 2012 1512 1520
18. P. Dutta, G. Courties, and Y. Wei Myocardial infarction accelerates atherosclerosis Nature 487 2012 325 329
19. A.M. Kaynar, S. Yende, and L. Zhu Effects of intra-abdominal sepsis on atherosclerosis in mice Crit Care 18 2014 469
20. F.K. Swirski, P. Libby, and E. Aikawa Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata J Clin Invest 117 2007 195 205
21. F. Tacke, D. Alvarez, and T.J. Kaplan Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques J Clin Invest 117 2007 185 194
22. T. Seijkens, M.A. Hoeksema, and L. Beckers Hypercholesterolemia-induced priming of hematopoietic stem and progenitor cells aggravates atherosclerosis FASEB J 28 2014 2202 2213
23. E. van Kampen, A. Jaminon, T.J. van Berkel, and M. Van Eck Diet-induced (epigenetic) changes in bone marrow augment atherosclerosis J Leukoc Biol 96 2014 833 841
24. J. Van den Bossche, A.E. Neele, M.A. Hoeksema, and M.P. deWinther Macrophage polarization: the epigenetic point of view Curr Opin Lipidol 25 2014 367 373
25. T. Kouzarides Chromatin modifications and their function Cell 128 2007 693 705
26. A.J. Bannister, and T. Kouzarides Regulation of chromatin by histone modifications Cell Res 21 2011 381 395
27. E.L. Greer, and Y. Shi Histone methylation: a dynamic mark in health, disease and inheritance Nat Rev Genet 13 2012 343 357
28. B.E. Bernstein, A. Meissner, and E.S. Lander The mammalian epigenome Cell 128 2007 669 681
29. M.G. Netea, J. Quintin, and J.W. van der Meer Trained immunity: a memory for innate host defense Cell Host Microbe 9 2011 355 361
30. O. Levy, and M.G. Netea Innate immune memory: implications for development of pediatric immunomodulatory agents and adjuvanted vaccines Pediatr Res 75 2014 184 188
31. M.G. Netea Training innate immunity: the changing concept of immunological memory in innate host defence Eur J Clin Invest 43 2013 881 884
32. S. Saeed, J. Quintin, and H.H. Kerstens Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity Science 345 2014 1251086
33. S.C. Cheng, J. Quintin, and R.A. Cramer mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity Science 345 2014 1250684
34. J. Kleinnijenhuis, J. Quintin, and F. Preijers Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes Proc Natl Acad Sci U S A 109 2012 17537 17542
35. J. Kleinnijenhuis, J. Quintin, and F. Preijers Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity J Innate Immun 6 2014 152 158
36. J. Quintin, S. Saeed, and J.H. Martens Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes Cell Host Microbe 12 2012 223 232
37. R. Ostuni, V. Piccolo, and I. Barozzi Latent enhancers activated by stimulation in differentiated cells Cell 152 2013 157 171
38. D.R. Donohoe, and S.J. Bultman Metaboloepigenetics: interrelationships between energy metabolism and epigenetic control of gene expression J Cell Physiol 227 2012 3169 3177
39. S. Bekkering, L.A. Joosten, and J.W. van der Meer Trained innate immunity and atherosclerosis Curr Opin Lipidol 24 2013 487 492
40. D.J. Lamb, L.J. Eales, and G.A. Ferns Immunization with bacillus Calmette-Guerin vaccine increases aortic atherosclerosis in the cholesterol-fed rabbit Atherosclerosis 143 1999 105 113
41. S. Bekkering, J. Quintin, and L.A. Joosten Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes Arterioscler Thromb Vasc Biol 34 2014 1731 1738
42. D. Wagsater, C. Zhu, and J. Bjorkegren MMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclerosis development in the Ldlr(-/-)Apob(100/100) mouse Int J Mol Med 28 2011 247 253
43. D. Pons, F.R. de Vries, and P.J. van den Elsen Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease Eur Heart J 30 2009 266 277
44. R.J. Wierda, S.B. Geutskens, and J.W. Jukema Epigenetics in atherosclerosis and inflammation J Cell Mol Med 14 2010 1225 1240
45. A.L. Webster, M.S. Yan, and P.A. Marsden Epigenetics and cardiovascular disease Can J Cardiol 29 2013 46 57
46. J. Loscalzo, and D.E. Handy Epigenetic modifications: basic mechanisms and role in cardiovascular disease (2013 Grover Conference series) Pulm Circ 4 2014 169 174
47. G. Lund, and S. Zaina Atherosclerosis: an epigenetic balancing act that goes wrong Curr Atheroscler Rep 13 2011 208 214
48. Y.R. Kim, C.S. Kim, and A. Naqvi Epigenetic upregulation of p66shc mediates low-density lipoprotein cholesterol-induced endothelial cell dysfunction Am J Physiol Heart Circ Physiol 303 2012 H189 H196
49. S. Mitra, M. Khaidakov, and J. Lu Prior exposure to oxidized low-density lipoprotein limits apoptosis in subsequent generations of endothelial cells by altering promoter methylation Am J Physiol Heart Circ Physiol 301 2011 H506 H513
50. G.H. Eom, and H. Kook Posttranslational modifications of histone deacetylases: implications for cardiovascular diseases Pharmacol Ther 143 2014 168 180
51. S.S. Xu, S. Alam, and A. Margariti Epigenetics in vascular disease - therapeutic potential of new agents Curr Vasc Pharmacol 12 2014 77 86
52. Y. Wang, T. Chen, and H. Yan Role of histone deacetylase inhibitors in the aging of human umbilical cord mesenchymal stem cells J Cell Biochem 114 2013 2231 2239
53. P. Dje N'Guessan, F. Riediger, and K. Vardarova Statins control oxidized LDL-mediated histone modifications and gene expression in cultured human endothelial cells Arterioscler Thromb Vasc Biol 29 2009 380 386
54. B. Schmeck, W. Beermann, and P.D. N'Guessan Simvastatin reduces Chlamydophila pneumoniae-mediated histone modifications and gene expression in cultured human endothelial cells Circ Res 102 2008 888 895
55. A. Zampetaki, L. Zeng, and A. Margariti Histone deacetylase 3 is critical in endothelial survival and atherosclerosis development in response to disturbed flow Circulation 121 2010 132 142
56. F.E. Alkemade, P. van Vliet, and P. Henneman Prenatal exposure to apoE deficiency and postnatal hypercholesterolemia are associated with altered cell-specific lysine methyltransferase and histone methylation patterns in the vasculature Am J Pathol 176 2010 542 548
57. I. Tabas, and C.K. Glass Anti-inflammatory therapy in chronic disease: challenges and opportunities Science 339 2013 166 172
58. M.A. Hoeksema, M.J. Gijbels, and J. Van den Bossche Targeting macrophage histone deacetylase 3 stabilizes atherosclerotic lesions EMBO Mol Med 6 2014 1124 1132
59. C. Bellenguez, S. Bevan, and A. Gschwendtner Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke Nat Genet 44 2012 328 333
60. Q. Cao, S. Rong, and J.J. Repa Histone deacetylase 9 represses cholesterol efflux and generation of alternatively activated macrophages in atherosclerosis development Arterioscler Thromb Vasc Biol 34 2014 1871 1879
61. D.B. Seligson, S. Horvath, and T. Shi Global histone modification patterns predict risk of prostate cancer recurrence Nature 435 2005 1262 1266
62. B. Pachaiyappan, and P.M. Woster Design of small molecule epigenetic modulators Bioorg Med Chem Lett 24 2014 21 32
63. A. Nebbioso, V. Carafa, R. Benedetti, and L. Altucci Trials with 'epigenetic' drugs: an update Mol Oncol 6 2012 657 682
64. M.R. Shakespear, M.A. Halili, and K.M. Irvine Histone deacetylases as regulators of inflammation and immunity Trends Immunol 32 2011 335 343
65. J.H. Choi, K.H. Nam, and J. Kim Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice Arterioscler Thromb Vasc Biol 25 2005 2404 2409
66. X.Q. Zhang, O. Even-Or, and X. Xu Nanoparticles containing a liver X receptor agonist inhibit inflammation and atherosclerosis Adv Healthc Mater 2014 Aug 22 [E-pub ahead of print]
67. A.C. Anselmo, C.L. Modery-Pawlowski, and S. Menegatti Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries ACS Nano 8 2014 11243 11253
68. M. Howard, B.J. Zern, and A.C. Anselmo Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm ACS Nano 8 2014 4100 4132
69. R. Duivenvoorden, J. Tang, and D.P. Cormode A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation Nat Commun 5 2014 3065
70. W.J. Mulder, F.A. Jaffer, Z.A. Fayad, and M. Nahrendorf Imaging and nanomedicine in inflammatory atherosclerosis Sci Transl Med 6 2014 239sr1